A Prospective, Observational Study of Patients With Cervical Dystonia (Dystonie) Treated With OnabotulinumtoxinA

Study Identifier
CMA-BTX-12-001
CT.gov Identifier
EudraCT Identifier
Not available
EUCTIS ID
Not available
For general inquiries, please contact
Study Complete

Study Details

Medical Condition
  • Neuroscience - Other
  • Study Drug
  • OnabotulinumtoxinA
  • Phase
    N/A
    Sex
    Female & Male
    Age
    16+ years

    Protocol Summary

    This is an observational study to assess health-related quality of life in patients with cervical dystonia (dystonie) treated with OnabotulinumtoxinA per routine clinical practice.

    Study Locations

    Location
    Status
    Location
    Clinique Neuro-Rive Sud
    Greenfield Park, Quebec, Canada, J4V 2J2
    Status
    Not applicable
    Location
    Hôpital Maisonneuve-Rosemont
    Montreal, Quebec, Canada, H1T 2M4
    Status
    Not applicable
    Location
    Chum-Notre-Dame
    Montreal, Quebec, Canada, H2L 4M1
    Status
    Not applicable
    Location
    Queen Elizabeth Health Centre: Medical Specialist Clinic
    Montreal, Quebec, Canada, H4A 3L5
    Status
    Not applicable
    Location
    CHU de Québec, Hôpital de l'Enfant-Jésus
    Québec, Quebec, Canada, G1J 1Z4
    Status
    Not applicable
    Location
    Centre Medical Le Mesnil
    Québec, Quebec, Canada, G2K 0H1
    Status
    Not applicable
    Showing {first} - {last} of {total} Results